# Early Neutralizing Antibodies in Infants Living With HIV to Enhance Their Life

> **NCT07655128** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Hospital Universitario 12 de Octubre** · enrollment: 87 (estimated)

## Conditions studied

- HIV -1 Infection

## Interventions

- **DRUG:** Broadly neutralizing antibody (bNAb) ePGT121v1-LS
- **DRUG:** Saline (0.9% NaCl)

## Key facts

- **NCT ID:** NCT07655128
- **Lead sponsor:** Hospital Universitario 12 de Octubre
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01-01
- **Primary completion:** 2029-07-01
- **Final completion:** 2029-12-31
- **Target enrollment:** 87 (ESTIMATED)
- **Last updated:** 2026-08-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07655128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07655128, "Early Neutralizing Antibodies in Infants Living With HIV to Enhance Their Life". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07655128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*